C-GAEO21st Century Medicine
hypothermic preservation, cryopreservation, Bio Logistics
preservationcryonics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-GAEO
C-GAEOC-GAEOhypothermic preservation, cryopreservation, Bio Logistics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Brian Wowk is a biophysicist employed as a Senior Scientist at 21st Century Medicine, Inc., a company specializing in low temperature preservation of tissue and organs for medical applications. He holds M.Sc. and Ph.D. degrees in medical physics, specializing in radiation oncology physics and magnetic resonance imaging. The premise of cryonics is the preservation of sufficient information, especially brain information, to permit recovery of the original person. Studies show steady progress in the quality with which brain information can be preserved under ideal conditions. However the absence of demonstrable reversibility, and the vast variety of conditions under which cryopreservations can take place, introduce uncertainty in the “information theoretic” paradigm of cryonics. Dr. Wowk discusses what cryobiology says about the prospects of cryonics actually working.
Brian Wowk, from 21st Century Medicine, presents: "Metastable vitrification of cryoprotectant solutions" at CRYO2013, the annual conference of the Society for Cryobiology, held July 28-31 2013 in Washington, DC. Visit us online at: http://www.societyforcryobiology.org/ Like us on FB: https://www.facebook.com/SocietyforCryobiology Follow us on Twitter: https://twitter.com/SocietyCryobiol
人体冷凍保存技術 Conference 2025｜長寿医療の未来を語る国際会議レポート Japan Longevity Insider ロンジェビティムーブメント情報をイベント・テクノロジー・クリニック・人物・企業まで幅広くカバーするロンジェビティコンテンツハブ Home NEWS People Event Technology Investment Clinic Interview Blog Contact News Ticker [ 2026-06-08 ] Aging Loop #14｜免疫老化ループ — 免疫システムの劣化が老化と炎症の悪循環を作る｜Japan Longevity Insider Aging Loop [ 2026-06-07 ] Aging Loop #13｜プロテオスタシス崩壊ループ — タンパク質の「品質管理」が失われると老化が加速する｜Japan Longevity Insider Aging Loop [ 2026-06-03 ] Aging Loop #12｜テロメア短縮ループ — 染色体の「保護キャップ」が失われると老化が加速する｜Japan Longevity Insider Aging Loop [ 2026-05-30 ] Aging Loop #11｜オートファジー低下ループ — 細胞の「掃除機能」が止まると老化が加速する｜Japan
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Transforming epidemiology for 21st century medicine and public health - Johns Hopkins University Skip to main navigation Skip to search Skip to main content Johns Hopkins University Home Search content at Johns Hopkins University Home Profiles Research units Research output Transforming epidemiology for 21st century medicine and public health Muin J. Khoury , Tram Kim Lam , John P.A. Ioannidis , Patricia Hartge , Margaret R. Spitz , Julie E. Buring , Stephen J. Chanock , Robert T. Croyle , Katrina A. Goddard , Geoffrey S. Ginsburg , Zdenko Herceg , Robert A. Hiatt , Robert N. Hoover , David J. … similar technologies. For all open access content, the relevant licensing terms apply We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies About web accessibility Link opens in a new tab Report vulnerability Link opens in a new tab
Home - Vitalist Bay 0 % Sponsor Join May 14 – 17 2026 Join Longevity's New Capital VITALIST BAY SIGN UP 100+ speakers Lighthaven, Berkeley. 200+ Companies Four days. 150+ workshops & talks 100+ speakers 18 activities & health tests 2026 Speakers Day 1 THU May 14 Main Investors Replacement Adam Gries Founder Vitalism Carsten Charlesworth Postdoctoral Researcher Stanford University Christine Peterson Co-Founder Foresight Institute Daniel Burger Founder Eightsix Science Derya Unutmaz Professor The Jackson Laboratory Dylan McGuire Founder Aleph Surgical Emil Kendziorra Emil Kendziorra … Verdin President and CEO The Buck Institute Jamie Justice Executive Director X-Prize Healthspan Jarod Rutledge Director of Biotechnology Investments Starbloom Capital Jean Hebert Program Director ARPA-H Kayla Barnes-Lentz Founder The Female Longevity Protocol Kris Borer Angel investor krisborer.com Laura Minquini Founder AthenaBIO Nathan Price Professor & Co-Director, Center for Human Healthspan Buck Institute Omri Amirav-Drory General Partner Nfx Bio Patri Friedman Gene … ti-Retirement Club, Beusail longevity forums Danielle Strachman Co-Founder 1517 Fund Elaine Shi Co-Founder and CEO Bodyspec Eli Berlin Co-Founder, COO and CFO Terray Therapeutics Eric Morgen COO BioAge Hank Greely Professor of Law, Genetics Stanford University Jarod Rutledge Director of Biotechnology Investments Starbloom Capital Justin Rebo CEO Kind Biotechnology Karl Pfleger Founder Aging Biotech Info Kelsey Moody CEO, Founder, Angel Investor Ichor Life Sciences Kevin Caldw … tive Armand Cognetta CEO General Proximity Dave Messina General Partner Pioneer Fund Derya Unutmaz Professor The Jackson Laboratory Eli Mohamad Space Biostasis Coalition Fabian Suchy Co-founder, Scientist Nakauchi Lab, Stanford University Farbood Nivi Founder A-List Gloria Eliott Program Manager ARPA-H Greg Fahy Chief Scientific Officer 21st Century Medicine / Intervene Immune Jamie Heywood CEO & Chairman Alden Scientific Jeff Chen Co-founder & CEO Radicle Science Joh … Grua Chief of Staff · BodySpec Roxana Grunenwald Partner, Cofounder · Dorm Room Fund, Biopunk Pasha Gurevich VP Product · Elo Health Lou Hawthorne CEO · Nanotics Motoshi Hayano Associate Professor & CEO · Tokyo University of Science & ASAGI Labs Chong He Partner at LiveBeyond / Principal Investigator · LiveBeyond.ai Jean Hebert Program Di
21st Century Medicine - Wikipedia Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Contents move to sidebar hide (Top) 1 References 2 External links Toggle the table of contents 21st Century Medicine 2 languages Polski Русский Edit links Article Talk English Read Edit View history Tools Tools move to sidebar hide Acti … e of vitrification . 21CM was founded in 1993. In 2004 21CM received a $900,000 grant from the U.S. National Institutes of Health (NIH) to study a preservation solution developed by the University of Rochester in New York for extending simple cold storage time of human hearts removed for transplant . [ 1 ] At the July 2005 annual conference of the Society for Cryobiology , 21st Century Medicine announced the vitrification of a rabbit kidney to −135 °C with their … February 9, 2016, 21st Century Medicine won the Small Mammal Brain Preservation Prize . [ 4 ] On March 13, 2018, they won the Large Mammal Brain Preservation Prize . [ 5 ] References [ edit ] ^ "NIH grant to be used for heart preservation research" . Business Wire. October 31, 2004. Archived from the original on March 5, 2016 . Retrieved May 2, 2012 . ^ "Plenary Session: Fundamentals of Biopreservation" . CRYO 2005 Scientific Program . Society for Cryobiology. … the Creative Commons Attribution-ShareAlike 4.0 License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. , a non-profit organization. Privacy policy About Wikipedia Disclaimers Contact Wikipedia Legal & safety contacts Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents 21st Century Medicine 2
21st Century Medicine --Expanding the Boundaries of Preservation Science BIO-PHARMACEUTICALS TRANSPLANTATION ASSISTED REPRODUCTIVE TECHNOLOGIES POTENTIAL APPLICATIONS NEWS INVESTORS MANAGEMENT CAREERS SERVICES SOLUTIONS STORAGE CRYOBIOLOGY PUBLICATIONS LINKS It’s A Matter Of Time 21st Century Medicine has developed an entire platform technology focused on the creation and commercialization of hypothermic preservation and cryopreservation techniques that enable protection, preservation, transportation, storage & future use of valuable living systems. These developments have taken science fa
thinking about signing up - Page 2 - Cryonics - LONGECITY - Page 2 ....................... Google Sign in options Remember me This is not recommended for shared computers Sign in anonymously Don't add me to the active users list Privacy Policy Sign In Create Account ::: --> L onge C ity Advocacy & Research for Unlimited Lifespans .org About UserAgreement Constitution Stewards MembersList Districts Homepage Portal Forum Blogs FacebookPage Media Newsletter
21CM Patent: Some answers and questions X-Message-Number: 12464 Date: Tue, 28 Sep 1999 01:19:37 -0400 From: Mike Darwin < > Subject: 21CM Patent: Some answers and questions There have been a number of comments and speculations on the recently published 21st Century Medicine (21CM) assigned patent on novel cryoprotectants. In particular, Robert Ettinger and Thomas Donaldson have expressed puzzlement about the lack of supporting data for the high rates of cooling claimed, and also as to the "legitimacy" of the core patent claims themselves. For instance, Ettinger writes (as quoted in the f … ore to preserve embryos and cell suspensions, but believe they have priority in application to tissues, organs, and animals. Obviously, there are potentially interesting questions in patent law--both as to the relation between these inventors and prior users of glycol ethers, and between these inventors and later users of new variations and applications." Donaldson also states: "There is also some question in my own mind about whether or not some of the perfusion methods desc … ver conventional cryoprotectants in many situations. However, that is *not* the application that is being claimed in the 21CM patent. Rather, it is the use of these compounds in clever ways to achieve *vitrification*: cryopreservation in the absence of damaging amounts of ice, wherein the organ system or tissueis maintained in a largely or completely glassy or otherwise non-crystalline state. Freezing is a workable method for cryopreservation of of many cells, small organisms … ion sufficient to permit vitrification and cooling until >vitrified; and the application of this to any organ, tissue, or animal. More >specific claims relate to use of 2-methoxyethanol and >3-methoxy-1,2-propanediol. >The inventors acknowledge that glycol ethers have been used before to >preserve embryos and cell suspensions, but believe they have priority in >application to tissues, organs, and animals. Obviously, there are potentially >interesting ques … t >microscopic and ultrasturctural levels." >References include Skrecky's proposal in Cryonet #5174, 1995; CRYONICS: >REACHING FOR TOMORROW (Wowk & Darwin, 1991; and THE PROSPECT OF IMMORTALITY, >1964; and a Darwin/Hixon piece in CRYONICS July 1984, as well as various >patents and publications in recognized journals. >I have
extropians: fwd: cryosuspension progress--21CM patent fwd: cryosuspension progress--21CM patent Jeff Davis ( [email protected] ) Tue, 21 Sep 1999 11:42:26 -0700 Messages sorted by: [ date ] [ thread ] [ subject ] [ author ] [ Next ] [ Previous ] Next in thread: Eugene Leitl >From the cryonet: >Message #12443 >From: [email protected] >Date: Mon, 20 Sep 1999 14:08:22 EDT >Subject: 21CM patent > >Go to www.uspto.gov to access the full text of the patent (Sep.14) assigned >to 21st Century Medicine Inc. Oddly enough, the inventors listed do not >include Greg Fahy; t … ion sufficient to permit vitrification and cooling until >vitrified; and the application of this to any organ, tissue, or animal. More >specific claims relate to use of 2-methoxyethanol and >3-methoxy-1,2-propanediol. > >The inventors acknowledge that glycol ethers have been used before to >preserve embryos and cell suspensions, but believe they have priority in >application to tissues, organs, and animals. Obviously, there are potentially >interesting … ;microscopic and ultrasturctural levels." > >References include Skrecky's proposal in Cryonet #5174, 1995; CRYONICS: >REACHING FOR TOMORROW (Wowk & Darwin, 1991; and THE PROSPECT OF IMMORTALITY, >1964; and a Darwin/Hixon piece in CRYONICS July 1984, as well as various >patents and publications in recognized journals. > >I have not found any patent entries under "ice blockers," although the >instant patent says that suppression of ice formation is a
Brian G. Wowk - Chief Technology Officer at 21st Century Medicine | The Org Platform Enrich Pricing Log in Sign up 21st Century Medicine Brian G. Wowk Unverified BW Brian G. Wowk Chief Technology Officer Contact Brian G. Wowk is the Chief Technology Officer of 21st Century Medicine responsible for developing a variety of cryobiological technologies. He was the discoverer of the ice-blocking properties of what is now our Supercool X-1000 product and was able to define the antinucleation properties of our Supercool Z-1000 product and demonstrate the synergistic effects of these two ice blocker
21st Century Medicine --Science & Business Management Teams BIO-PHARMACEUTICALS TRANSPLANTATION ASSISTED REPRODUCTIVE TECHNOLOGIES POTENTIAL APPLICATIONS NEWS INVESTORS MANAGEMENT CAREERS SERVICES SOLUTIONS STORAGE CRYOBIOLOGY PUBLICATIONS LINKS Business Management Team Gregory M. Fahy, Ph.D. Dr. Fahy is the Executive Director of 21st Century Medicine, Inc. He manages the strategic focus of the company's highly specialized research projects and is responsible, in cooperation with the Chief Operating Officer, for relationships with other businesses and for the general management of 21st Cen … ates in the strategic mission of the company. He manages regulatory compliance, grant reporting, supply chain issues, personnel and payroll issues, research databases, and sales of all 21st Century Medicine products, including our X1000 and Z1000 ice blockers and our cryoprotectant solutions. He brings to the company more than twenty years of prior proven leadership experience establishing corporate policy and objectives, designing quality systems and performing risk analysis … cryopreservation by vitrification and the inventor of computer based systems to apply this technology to whole organs. While at the Naval Medical Research Institute in Bethesda, Maryland, he spearheaded the original concept of ice blocking agents. Since joining 21st Century Medicine, he invented tonicity-mediated chilling injury control, the qv* system for predicting the toxicity of complex cryoprotectant solutions for organized tissues, and the DFE series of cryoprotectant s